SEC Form 4 · accession 0001225208-19-003739

BOSTON SCIENTIFIC CORP · BSX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chairman, President & CEO · Director

Period of report

Feb 22, 2019

Accepted (ET)

Feb 26, 2019 · 4:35 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000885725

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock^F1	Feb 22, 2019	M	23,175	$0.00	A	1,997,705	D
Common Stock	Feb 22, 2019	F	10,302	$40.52	D	1,987,403	D
Common Stock^F1	Feb 23, 2019	M	23,759	$0.00	A	2,011,162	D
Common Stock	Feb 23, 2019	F	10,561	$40.52	D	2,000,601	D
Common Stock^F1	Feb 24, 2019	M	29,052	$0.00	A	2,029,653	D
Common Stock	Feb 24, 2019	F	12,914	$40.52	D	2,016,739	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Deferred Stock Units^F1,F2	—	Feb 22, 2019	M	23,175	D	—	Feb 22, 2021	Common Stock	23,175	46,350	D
Deferred Stock Units^F1,F3	—	Feb 23, 2019	M	23,759	D	—	Feb 23, 2020	Common Stock	23,759	23,759	D
Deferred Stock Units^F1,F4	—	Feb 24, 2019	M	29,052	D	—	Feb 24, 2019	Common Stock	29,052	0	D

F1Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.
F3Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant.
F4Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.